Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Japan Free Press.
Press releases published on April 8, 2025

AI-Powered Drive Failure Prediction Now for Windows with DA SmartQuest
ULINK Technology officially releases DA SmartQuest, a PC application that introduces the DA Drive Analyzer drive failure prediction service to everyday PC users SANTA CLARA, CA, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- ULINK Technology, a …

Electe Joins the World Wide Web Consortium as a AI B2B Go-to-Market Leader
Italian AI analytics platform becomes W3C member to influence data interoperability and privacy standards for small and medium-sized enterprises MILANO, MI, ITALY, April 8, 2025 /EINPresswire.com/ -- Electe, an Italian company leading in AI-based data …

Quorum Software Introduces QAI: GenAI Chatbot for Upstream On Demand Land Software
In-App Answers and Assistance Enhances User Productivity and Accelerates Performance HOUSTON, TX, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- Quorum Software, a global leader in energy software, today announced the launch of its Quorum AI (QAI) …

First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced enrollment of the …

Market Research Center Launches Global Magnesium Oxide Nanopowder Industry (2025–2032) Report
The global magnesium oxide nanopowder market is projected to grow from US$ 30.51 Bn in 2025 to US$ 42.75 Bn by 2032, driven by its multifunctional use. TOKYO, JAPAN, April 8, 2025 /EINPresswire.com/ -- Market Research Center Corporation (MRCC), a global …

Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA
SAN DIEGO and TOKYO, April 08, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA, “Kura”), and Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”), today announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once- …